BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27958361)

  • 21. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
    Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment.
    Myers KV; Amend SR; Pienta KJ
    Mol Cancer; 2019 May; 18(1):94. PubMed ID: 31088471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice.
    Yu P; Qian AS; Chathely KM; Trigatti BL
    Atherosclerosis; 2018 Sep; 276():171-181. PubMed ID: 29853191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation.
    Sandahl M; Hunter DM; Strunk KE; Earp HS; Cook RS
    BMC Dev Biol; 2010 Dec; 10():122. PubMed ID: 21192804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TAM receptors and their ligand-mediated activation: Role in atherosclerosis.
    Cai B; Kasikara C
    Int Rev Cell Mol Biol; 2020; 357():21-33. PubMed ID: 33234243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of EP4 receptors on bone marrow-derived cells enhances inflammation in atherosclerotic lesions.
    Tang EH; Shimizu K; Christen T; Rocha VZ; Shvartz E; Tesmenitsky Y; Sukhova G; Shi GP; Libby P
    Cardiovasc Res; 2011 Jan; 89(1):234-43. PubMed ID: 20736236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perilipin1 deficiency in whole body or bone marrow-derived cells attenuates lesions in atherosclerosis-prone mice.
    Zhao X; Gao M; He J; Zou L; Lyu Y; Zhang L; Geng B; Liu G; Xu G
    PLoS One; 2015; 10(4):e0123738. PubMed ID: 25855981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.
    Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F
    Cardiovasc Res; 2010 May; 86(2):321-9. PubMed ID: 20110335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.
    Caravaggio JW; Hasu M; MacLaren R; Thabet M; Raizman JE; Veinot JP; Marcel YL; Milne RW; Whitman SC
    Cardiovasc Pathol; 2013; 22(6):458-64. PubMed ID: 23684818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders.
    Gadiyar V; Patel G; Chen J; Vigil D; Ji N; Campbell V; Sharma K; Shi Y; Weiss MM; Birge RB; Davra V
    Front Immunol; 2023; 14():1135373. PubMed ID: 37545504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Axl receptor tyrosine kinase is a discriminator of macrophage function in the inflamed lung.
    Fujimori T; Grabiec AM; Kaur M; Bell TJ; Fujino N; Cook PC; Svedberg FR; MacDonald AS; Maciewicz RA; Singh D; Hussell T
    Mucosal Immunol; 2015 Sep; 8(5):1021-1030. PubMed ID: 25603826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DBA/2J Haplotype on Distal Chromosome 2 Reduces Mertk Expression, Restricts Efferocytosis, and Increases Susceptibility to Atherosclerosis.
    Kayashima Y; Makhanova N; Maeda N
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):e82-e91. PubMed ID: 28473436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity.
    Nguyen KQ; Tsou WI; Calarese DA; Kimani SG; Singh S; Hsieh S; Liu Y; Lu B; Wu Y; Garforth SJ; Almo SC; Kotenko SV; Birge RB
    J Biol Chem; 2014 Sep; 289(37):25737-49. PubMed ID: 25074939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axl deficiency does not affect adipogenesis or adipose tissue development.
    Scroyen I; Frederix L; Lijnen HR
    Obesity (Silver Spring); 2012 Jun; 20(6):1168-73. PubMed ID: 22187042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hematopoietic Stabilin-1 deficiency does not influence atherosclerosis susceptibility in LDL receptor knockout mice.
    Nahon JE; Hoekstra M; van Hulst S; Manta C; Goerdt S; Geerling JJ; Géraud C; Van Eck M
    Atherosclerosis; 2019 Feb; 281():47-55. PubMed ID: 30658191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.
    Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G
    Elife; 2014 Sep; 3():. PubMed ID: 25265470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance of Macrophage Redox Status by ChREBP Limits Inflammation and Apoptosis and Protects against Advanced Atherosclerotic Lesion Formation.
    Sarrazy V; Sore S; Viaud M; Rignol G; Westerterp M; Ceppo F; Tanti JF; Guinamard R; Gautier EL; Yvan-Charvet L
    Cell Rep; 2015 Oct; 13(1):132-144. PubMed ID: 26411684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
    Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
    Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial Oxidative Stress Promotes Atherosclerosis and Neutrophil Extracellular Traps in Aged Mice.
    Wang Y; Wang W; Wang N; Tall AR; Tabas I
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):e99-e107. PubMed ID: 28596373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
    Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
    Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.